NEPHROLOGY / BASIC RESEARCH
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Chronic kidney disease (CKD) contributes to 1.2 million deaths annually. Oral dysbiosis may influence CKD, highlighting the need for further research on its role as a risk factor and preventive target.

Material and methods:
We obtained summary statistics for genome-wide association studies (GWAS) of the oral microbiome from the GWAS Catalog and CKD from the CKDGen Consortium. Inverse variance weighting (IVW) was used as the principal analysis method, supplemented by MR-Egger, weighted median, and weighted mode to assess causal relationships. Sensitivity analyses, including MR-PRESSO and Cochran’s Q, validated the robustness of the results.

Results:
The IVW results showed that Veillonella species was causally associated with CKD (OR = 0.96, 95% CI (0.93–0.99)), Order Fusobacteriales (OR = 1.01, 95% CI (1–1.01)) and Rothia species (OR = 0.99, 95% CI (0.99–1)) were causally associated with urinary albumin-to-creatinine ratio (UACR); Order Bacteroidales (OR = 0.97, 95% CI (0.94–1)) and Species micronuciformis (OR = 0.95, 95% CI (0.91–0.99)) were causally associated with CKDi25; and Streptococcus species was causally associated with dialysis (OR = 0.82, 95% CI (0.69–0.97)). There was no significant causal association between other oral microbiome features and CKD at the genetic level. Sensitivity analysis indicated that the results were robust.

Conclusions:
Our study suggests that there are associations between the oral microbiome and CKD. To better understand its mechanism of action and to develop broader strategies for preventing chronic kidney disease, further research is required.
REFERENCES (45)
1.
Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Chronic kidney disease. Lancet 2021; 398: 786-802.
 
2.
Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet 2017; 389: 1238-52.
 
3.
Cockwell P, Fisher LA. The global burden of chronic kidney disease. Lancet 2020; 395: 662-4.
 
4.
GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2020; 395: 709-33.
 
5.
Xie Y, Bowe B, Mokdad AH, et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int 2018; 94: 567-81.
 
6.
Lekskulchai V. Use of estimated glomerular filtration rate and urine albumin-to-creatinine ratio based on KDIGO 2012 guideline in a Thai Community Hospital: prevalence of chronic kidney disease and its risk factors. Med Sci Monit Basic Res 2022; 28: e938176.
 
7.
Thomas G. Hypertension management in chronic kidney disease and diabetes: lessons from the systolic blood pressure intervention trial. Cardiol Clin 2019; 37: 307-17.
 
8.
Wang H, Ainiwaer A, Song Y, et al. Perturbed gut microbiome and fecal and serum metabolomes are associated with chronic kidney disease severity. Microbiome 2023; 11: 3.
 
9.
Basilicata M, Pieri M, Marrone G, et al. Saliva as biomarker for oral and chronic degenerative non-communicable diseases. Metabolites 2023; 13: 889.
 
10.
Zhang Y, Wang X, Li H, Ni C, Du Z, Yan F. Human oral microbiota and its modulation for oral health. Biomed Pharmacother 2018; 99: 883-93.
 
11.
Peng X, Cheng L, You Y, et al. Oral microbiota in human systematic diseases. Int J Oral Sci 2022; 14: 14.
 
12.
Altamura S, Pietropaoli D, Lombardi F, Del Pinto R, Ferri C. An overview of chronic kidney disease pathophysiology: the impact of gut dysbiosis and oral disease. Biomedicines 2023; 11: 3033.
 
13.
Guo S, Wu G, Liu W, et al. Characteristics of human oral microbiome and its non-invasive diagnostic value in chronic kidney disease. Biosci Rep 2022; 42: BSR20210694.
 
14.
Campbell PM, Willmott T, Summers A, et al. Investigating oral microbiome dynamics in chronic kidney disease and post-transplantation in continuous culture. Microbiol Spectr 2024; 12: e0059824.
 
15.
Gan Y, Ruan D, Zeng Q, et al. Difference in oral microbiota composition between patients with stage 5 chronic kidney disease on hemodialysis and healthy controls. Am J Transl Res 2023; 15: 3342-54.
 
16.
Guo JZ, Xiao Q, Gao S, Li XQ, Wu QJ, Gong TT. Review of Mendelian randomization studies on ovarian cancer. Front Oncol 2021; 11: 681396.
 
17.
Holmes MV, Ala-Korpela M, Smith GD. Mendelian randomization in cardiometabolic disease: challenges in evaluating causality. Nat Rev Cardiol 2017; 14: 577-90.
 
18.
Mazidi M, Mikhailidis DP, Dehghan A, et al. The association between coffee and caffeine consumption and renal function: insight from individual-level data, Mendelian randomization, and meta-analysis. Arch Med Sci 2022; 18: 900-11.
 
19.
Köttgen A, Pattaro C. The CKDGen Consortium: ten years of insights into the genetic basis of kidney function. Kidney Int 2020; 97: 236-42.
 
20.
Stankevic E, Kern T, Borisevich D, et al. Genome-wide association study identifies host genetic variants influencing oral microbiota diversity and metabolic health. Sci Rep 2024; 14: 14738.
 
21.
Jiang R, Qu Q, Wang Z, Luo F, Mou S. Association between air pollution and bone mineral density: a Mendelian randomization study. Arch Med Sci 2024; 20: 1334-8.
 
22.
Zhang S, Ye T, Liu Y, et al. Research advances in clinical applications, anticancer mechanism, total chemical synthesis, semi-synthesis and biosynthesis of paclitaxel. Molecules 2023; 28: 7517.
 
23.
Palmer TM, Lawlor DA, Harbord RM, et al. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res 2012; 21: 223-42.
 
24.
Minelli C, Del Greco MF, van der Plaat DA, Bowden J, Sheehan NA, Thompson J. The use of two-sample methods for Mendelian randomization analyses on single large datasets. Int J Epidemiol 2021; 50: 1651-9.
 
25.
Sekula P, Del Greco MF, Pattaro C, Köttgen A. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol 2016; 27: 3253-65.
 
26.
Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 2016; 40: 304-14.
 
27.
Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol 2017; 46: 1985-98.
 
28.
Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants. Epidemiology 2017; 28: 30-42.
 
29.
Kulinskaya E, Dollinger MB. An accurate test for homogeneity of odds ratios based on Cochran’s Q-statistic. BMC Med Res Methodol 2015; 15: 49.
 
30.
Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan NA, Thompson JR. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol 2016; 45: 1961-74.
 
31.
Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 2018; 50: 693-8.
 
32.
Washio J, Shimada Y, Yamada M, Sakamaki R, Takahashi N. Effects of pH and lactate on hydrogen sulfide production by oral Veillonella spp. Appl Environ Microbiol 2014; 80: 4184-8.
 
33.
Lin D, Hu Q, Yang L, et al. The niche-specialist and age-related oral microbial ecosystem: crosstalk with host immune cells in homeostasis. Microb Genom 2022; 8: mgen000811b.
 
34.
Hu J, Iragavarapu S, Nadkarni GN, et al. Location-specific oral microbiome possesses features associated with CKD. Kidney Int Rep 2018; 3: 193-204.
 
35.
Aboushadi MM, Albelasy EH, Ordinola-Zapata R. Association between endodontic symptoms and root canal microbiota: a systematic review and meta-analysis of bacteroidetes, spirochaetes and fusobacteriales. Clin Oral Investig 2024; 28: 593.
 
36.
Krieger M, AbdelRahman YM, Choi D, et al. The prevalence of Fusobacterium nucleatum subspecies in the oral cavity stratifies by local health status. bioRxiv 2023; 2023: 10.25.563997.
 
37.
Corredor Z, Suarez-Molina A, Fong C, Cifuentes CL, Guauque-Olarte S. Presence of periodontal pathogenic bacteria in blood of patients with coronary artery disease. Sci Rep 2022; 12: 1241.
 
38.
Liu B, Mashimo C, Nambu T, Maruyama H, Okinaga T. Transposon insertion in Rothia dentocariosa. J Oral Biosci 2024; 66: 358-64.
 
39.
Zhang Y, Lo KL, Liman AN, Feng XP, Ye W. Tongue-coating microbial and metabolic characteristics in halitosis. J Dent Res 2024; 103: 484-93.
 
40.
Luo M, Sun M, Wang T, et al. Gut microbiota and type 1 diabetes: a two-sample bidirectional Mendelian randomization study. Front Cell Infect Microbiol 2023; 13: 1163898.
 
41.
Wu R, Ruan XL, Ruan DD, et al. Differences in gut microbiota structure in patients with stages 4-5 chronic kidney disease. Am J Transl Res 2021; 13: 10056-74.
 
42.
Zhao Y, Lukiw WJ. Bacteroidetes neurotoxins and inflammatory neurodegeneration. Mol Neurobiol 2018; 55: 9100-7.
 
43.
Van den Abbeele P, Grootaert C, Marzorati M, et al. Microbial community development in a dynamic gut model is reproducible, colon region specific, and selective for Bacteroidetes and Clostridium cluster IX. Appl Environ Microbiol 2010; 76: 5237-46.
 
44.
Baracco GJ. Infections caused by group C and G Streptococcus (Streptococcus dysgalactiae subsp. equisimilis and Others): epidemiological and clinical aspects. Microbiol Spectr 2019; 7: 10.1128/microbiolspec.gpp3-0016-2018.
 
45.
Garrido L, Lyra P, Rodrigues J, Viana J, Mendes JJ, Barroso H. Revisiting oral antiseptics, microorganism targets and effectiveness. J Pers Med 2023; 13: 332.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top